Healthcare Services

Breath biopsy testing market outlook (2026–2030) with growth drivers

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Breath Biopsy Testing Market Expected To Scale Between 2026 And 2030?

The breath biopsy testing market size has seen strong expansion in recent years. It is anticipated to grow from $3.43 billion in 2025 to $3.69 billion in 2026, registering a compound annual growth rate (CAGR) of 7.7%. The market’s growth during the historical period can be attributed to factors such as increased demand for non-invasive diagnostics, the advancement of clinical research on breath biomarkers, innovations in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a rising patient preference for painless testing methods.

The breath biopsy testing market is anticipated to experience substantial expansion over the coming years. Projections indicate it will reach a valuation of $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected increase is largely due to factors such as the greater acceptance of breath-based diagnostic methods in standard health screenings, heightened investments in AI-powered diagnostic platforms, the broadening scope of personalized medicine uses, the increasing deployment of portable diagnostic tools, and improved regulatory backing for non-invasive testing. Key developments expected during this period involve a rise in the adoption of non-invasive diagnostic approaches, growing utilization of VOC-based disease identification, enhanced incorporation of AI-driven breath analysis, the proliferation of portable breath sampling devices, and a stronger emphasis on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

What Key Factors Are Affecting The Breath Biopsy Testing Market Demand?

An increase in respiratory illnesses is anticipated to boost the expansion of the breath biopsy testing market in the future. These conditions are defined as health issues affecting the lungs and air passages, which impair effective breathing. The widespread occurrence of respiratory diseases stems from factors like escalating environmental pollution, elevated smoking rates, and the rising incidence of long-term ailments such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is necessary for respiratory diseases because it provides a non-invasive, quick, and potentially more precise approach for identifying biomarkers linked to these ailments, thereby enhancing early detection and treatment. For example, data from May 2025, provided by the Centers for Disease Control and Prevention (CDC), a U.S. government public health organization, indicated that chronic obstructive pulmonary disease (COPD) was the fifth primary cause of mortality in the United States in 2023, responsible for 141,733 deaths. In the same year, the age-adjusted rate of diagnosed COPD among adult individuals reached 3.8%. Consequently, the increasing occurrence of respiratory conditions will fuel the expansion of the breath biopsy testing market.

What Are The Different Segment Types In The Breath Biopsy Testing Market Segment Breakdown?

The breath biopsy testing market covered in this report is segmented –

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

Subsegments:

1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

What Trends Are Influencing Changes In The Breath Biopsy Testing Market?

Leading companies in the breath biopsy testing market are concentrating on developing advanced products, such as breath analyzers, for asthma detection. These diagnostic tools are designed to identify and quantify specific compounds in a person’s breath to pinpoint medical conditions or gauge health status. Illustratively, in May 2023, GenWorks, an India-based healthcare solutions provider, introduced the FenomPro breath analyzer. A key feature of the FenomPro breath analyzer is its rapid FeNO testing capability, which yields results in merely 28 seconds. Developed for easy operation in clinical settings, it delivers accurate assessments for diagnosing, screening, and monitoring asthma. The instrument also incorporates a rechargeable battery for portability, presents a user-friendly interface, and effectively helps determine if patients require treatment or inhaler prescriptions.

Who Are The Well-Known Companies In The Breath Biopsy Testing Market?

Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Get The Full Breath Biopsy Testing Market Report:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

Which Region Leads The Breath Biopsy Testing Market In Overall Market Size?

North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Breath Biopsy Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

Smart Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795